Webinar | October 12, 2021

Essential Strategies For Gene Therapy - From Assay Development To CDx Commercialization

Innovators developing gene therapies face a multitude of challenges, from the lab to the FDA. Yet a number of successful strategies are emerging that are mitigating the risks, reducing costs and smoothing out the road to approval. Listen to a panel of gene therapy experts with unique perspectives and real-world experiences share successful approaches in gene therapy development, CDx development and commercialization.

Attendees Will Hear:

  • Factors in the NAb vs. TAb assay choice, including respective assay development challenges and agency outlooks
  • How to make the most of early engagement and collaboration with regulatory agencies
  • How to plan and prepare for CDx development from the beginning of assay development
  • New approaches for CDx regulatory approval and commercialization

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene